Materiovigilance programme of India: a step towards patient safety
Keywords:Medical devices, Materiovigilance, Global harmonization task force
Medical devices which are indispensable part of healthcare delivery system may cause serious events for patients and contribute to healthcare costs. The robust materiovigilance programme will lead to improve the safety of patients and users by reducing the reoccurrence of the incidents. Furthermore, the existing incidents advocate continuous monitoring of medical devices in use, in order to protect the patients’ health. Post marketing surveillance of medical devices is done in many countries, but it is still not as developed and robust as that of medicines. Materiovigilance program of India was launched, at Indian pharmacopeia commission to monitor the adverse events associated with the use of medical devices, to generate safety data, create awareness among the different stakeholders, and recommend the best practices and interventions to improve the patient’s safety. This article reviews regulations and guidance documents regarding medical devices focused on post market vigilance framework in India along with measures for robust implementation of the existing programme.
Johnson JA. FDA Regulation of Medical Devices. CRS Report for Congress Prepared for Members and Committees of Congress. Available at: http://www.fas.org/sgp/crs/misc/ R42130.pdf. Accessed on 16 April, 2023.
Gupta SK. Medical Device regulations: A current perspective. J Young Pharm. 2016;8:6-11.
Mirel S. Materiovigilance and Medical Devices. In: Vlad S., Ciupa R. (eds) International Conference on Advancements of Medicine and Health Care through Technology Cluj-Napoca, Romania. IFMBE Proceedings, Springer, Cham. 2014;44.
Alsohime F, Temsah MH, Hasan G, Al-Eyadhy A, Gulman S, Issa H, Alsohime O. Reporting adverse events related to medical devices: A single centre experience from a tertiary academic hospital. PloS one. 2019;14(10):e0224233.
Heneghan C, Thompson M, Billingsley M, Cohen D. Medical-device recalls in the UK and the device-regulation process: Retrospective review of safety notices and alerts. BMJ Open. 2011;1:e000155.
Hauser RG. Here we go again-Another failure of post marketing device surveillance. N Engl J Med. 2012;366:873-5.
McGee RG, Webster AC, Rogerson TE, Craig JC. Medical device regulation in Australia: safe and effective? Med J Aust. 2012;196(4):256-60.
Saifuddin PK, Tandon M., Kalaisevalan V, Suroy B, Pattanshetti V, Prakash A et al. Materiovigilance Programme of India Current status and way forward. Indian J Pharmacol. 2022;54:221-5.
Global atlas of medical devices (WHO Medical device technical series). 2017. Available at: https://www.who.int/medical_devices/publications/global_atlas_meddev2017/en. Accessed on 19 February, 2023
International Medical Device Regulators Forum. Available at: http://www.imdrf.org/about/about.asp#mcm. Accessed on 15 February, 2023.
Global harmonization Task Forces. Available at: https://www.who.int/medical_devices/collaborations/force/en/. Accessed on 17 February, 2023.
Materiovigilance Programme of India (MvPI)-Indian Pharmacopoeia Commission. Available at: http://www.ipc.gov.in/mandates/pvpi/materiovigilanceprogramme-of-india-mvpi.html. Accessed on 16 January, 2023.
Singh RSK. Materiovigilance. An Emerging discipline. Int J Scientific Res. 2018;7(6):15-6.
Chouhan P., Zareen A., Iqubal MK. Current status of Materiovigilance globally – An Utter overview with clinical case pursual. Int J Pharmacy Pharmaceutical Sci. 2012;11(10)1-8.
Guidance Document Materio -vigilance Programme of India, 2015.; Available at: http://ipc.nic.in/writereaddata/mainlinkFile/File735.pdf. Accessed 10 February, 2023.
A guidance document for medical devices. Central drugs standard control organization; 2018. Available at: http://www.cdsco.nic.in/writereaddata/Guidance%20Document%20ipv.pdf. Accessed on 26 February 2023.
Pandey N, Mohammad I. Materiovigilance: Current status in India analogous to its global status. J Pharmacovigilance Drug Res. 2020:1(2);24-31.
Meher BR. Materiovigilance-An Indian Perspective. Perspective in clinical Res. 2018;9:(4):175-78.